双氢青蒿素逆转人肺腺癌细胞多药耐药作用研究

被引:5
作者
陈卫强
戚好文
吴昌归
李志奎
柏长青
刘颖格
机构
[1] 第四军医大学西京医院呼吸内科
关键词
双氢青蒿素; 肺癌; 顺铂; 耐药;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
目的观察双氢青蒿素和顺铂在体外对A549及A549/CDDP细胞的作用,分析双氢青蒿素抗肺癌和逆转耐药效果。方法采用细胞计数法绘制亲代A549细胞和A549/CDDP细胞生长曲线,细胞增殖及增殖抑制实验采用MTT检测法:A549/CDDP细胞分为顺铂单药作用组,联合作用组(100nM双氢青蒿素加顺铂,320nM双氢青蒿素加顺铂),序贯治疗组(100nM双氢青蒿素预处理),用MTT检测法分析计算IC50值进行比较。结果顺铂对人肺腺癌A549细胞和A549/CDDP细胞IC50值分别为0.270μg/ml和5.703μg/ml,耐药倍数为21.12。对A549/CDDP细胞,联合治疗100nM双氢青蒿素组顺铂IC50值为2.225μg/ml(逆转倍数2.56),320nM双氢青蒿素组顺铂IC50值0.464μg/ml(逆转倍数12.29)。对A549/CDDP细胞,序贯治疗组顺铂IC50为2.523μg/ml(逆转倍数2.26)。结论联合用药和序贯治疗均可逆转A549/CDDP细胞对顺铂的耐药。
引用
收藏
页码:284 / 286
页数:3
相关论文
共 8 条
[1]  
Cytotoxic sesquiterpene lactones from Carpesium abrotanoides. Lee J,Min B,Lee S,et al. Planta Medica . 2002
[2]  
Inhibition of glu-tathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Mukanganyama S,Widersten M,Naik YS,et al. International Journal of Cancer . 2002
[3]  
NMR studies of the relationshipbetween the changes of membrane lipids and the cisplatin-resist-ance of A549/DDP cells. Huang Z,Tong Y,Wang J,et al. Cancer Cell International . 2003
[4]  
Modulation of multidrug resistance by artemisinin,artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines. Reungpatthanaphong P,Mankhetkorn S. Biological and Pharmaceutical Bulletin . 2002
[5]  
Deoxyartemisinin deriva-tives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation. Galal AM,Ross SA,ElSohly MA,et al. Journal of Natural Products . 2002
[6]  
Significance of nuclear glutathi-one S-transferase pi in resistance to anti-cancer drugs. Goto S,Kamada K,Soh Y,et al. Japanese Journal of Cancer Research . 2002
[7]  
The effects of querce-tin vs cisplatin on proliferation and the apoptotic process in A549and SW1271cell lines in in vitro conditions. Borska S,Gebarowska E,Wysocka T,et al. Folia Morphologica . 2004
[8]  
Orally active,antimalarial,an-ticancer,artemisinin-derived trioxane dimmers with high stability and efficacy. Posner GH,Paik IH,Sur S,et al. Journal of Medicinal Chemistry . 2003